Clinical Trial Update: Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein [Phase 1]

View source ↗

Summary

A Phase I trial of HeFi-1 for cancers expressing CD34? expressing CD30? Wait: The document states CD30 proteins; the summary is updated here. A Phase I trial of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• HeFi-1

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neoplasms | Phase 1 | Status: COMPLETED